Guggulsterone.
The active steroid in guggul, the gum resin of the Indian bdellium tree. It works on FXR, the receptor through which your liver senses bile acids and adjusts their output.
- Category
- Herb
- Also called
- Gugglesterone
What Guggulsterone is, and what it does.
- Does it work
- It suits people using a traditional Ayurvedic resin, and formulators who want bile and lipid handling in a formula. Read whether the label says guggul or guggulsterones.
- How much to take
- No daily amount is on record. Crude resin, purified guggul and a 2.5 or 10 percent standardised extract carry very different quantities of the actual compound.
- Time to feel it
- No reliable human time course exists. The trials that have run lasted weeks to months and measured blood chemistry rather than sensation.
- The first dose
- The first day tends to be quiet apart from the bitter resin note and, in some people, a heavy stomach. Nothing measurable shifts in a day.
- With regular use
- Weeks of daily use is what the studies cover. What moves is bile acid and lipid chemistry on a panel, a slow change rather than a felt one.
- How well tolerated
- Digestive upset and skin rash are the usual reports. It raises CYP3A4 activity and can change the blood levels of prescribed medicines, so talk to a clinician first.
- How it feels
- There isn't much of a subjective experience. Some people notice the bitter resin and a full stomach, and that's the extent of it.
- The overlooked benefit
- It hits several nuclear receptors at laboratory concentrations, not one. That's why cell results are hard to pin on a single target and why the mechanism story stays open.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- FXR antagonism and bile acid feedbackIn vitro study
- PXR activation raising CYP3A4 expressionIn vitro study
- activity at several other steroid nuclear receptorsIn vitro study
- blood lipids already in the normal rangeRandomised trial
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Guggulsterone is characterised in the pharmacology literature as an antagonist at the farnesoid X receptor, while bile acids such as chenodeoxycholic acid are its natural agonists. Supplying bile acids alongside pushes the same receptor in the opposite direction. This is a genuine directional conflict at one target and deserves flagging in any formula that carries both.
Guggulsterone is a steroid-type molecule with very low water solubility that comes from a gum resin matrix. Phospholipid complexes are a standard way to disperse such molecules and keep them from recrystallising. The effect is on dispersion and dissolution, not on what the molecule does once it reaches a receptor.
A lipid vehicle keeps guggulsterone in solution through gastric transit rather than letting it precipitate. Fat in the meal also drives bile release and micelle formation, which is the route by which lipophilic compounds cross the enterocyte. How much of that translates into blood levels has not been quantified for this molecule in the sources available here.
Red yeast rice supplies monacolin K, which acts on cholesterol synthesis, while guggulsterone acts on nuclear receptor control of bile acid and cholesterol disposal. Different control points on one system can stack. Both also carry meaningful interaction potential with prescribed lipid medicines, so this pairing is one to raise with a clinician rather than assemble alone.
Berberine acts largely through AMPK activation and LDL receptor expression, guggulsterone through nuclear receptor antagonism. The targets do not overlap, which is the usual argument for combining them. Both are also substrates and modifiers of drug-metabolising enzymes, so combined use raises the chance of shifting the levels of prescribed medicines.
Guggulsterone has been reported to activate the pregnane X receptor, which raises expression of CYP3A4 and related transporters. Curcumin is more often described as inhibiting several of the same enzymes. Putting them together makes the net effect on any co-taken medicine hard to predict, which is worth saying plainly.
Silymarin is used for hepatocyte support and guggulsterone acts on bile acid signalling inside the same cell type. Formulators combine them on that logic. No study here tested the combination, so this stays a mechanistic pairing rather than a demonstrated one.
Iodine is the substrate for thyroid hormone synthesis, a settled biochemical requirement. Guggul preparations have been discussed in relation to thyroid hormone handling in older preclinical work of variable quality. Anyone taking thyroid medication should regard this pair as one to clear with a prescriber first.
EPA and DHA act largely on triglyceride synthesis and clearance, guggulsterone on nuclear receptor control of bile acid and sterol disposal. Because the entry points differ, combining them is a common formulation choice. There is no trial of the pair in the sources available here.
Nothing specific on file for Guggulsterone. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Guggulsterone actually does.
Guggulsterone is a plant steroid compound that occurs in two mirror-image forms, and guggul extracts are typically measured for both together.
It's extracted from the resin of the Indian bdellium tree, which is tapped from the trunk much the way myrrh is collected.
Because it's a fat-soluble steroid, absorbing it depends on bile salts forming micelles, and it's better absorbed when taken with some dietary fat.
Guggulsterone is a plant steroid pulled from the resin of the guggul tree, and it comes in two mirror-image forms that commercial products sell together as a pair.
The forms it comes in.
The essence, in one line each.
- Manipulating farnesoid X receptor signalling changed lipid handling in calf hepatocytes exposed to a high fat load, with guggulsterone named among the tools used to act on that receptor.In vitro study. Jia B et al., 2026 (Frontiers in Veterinary Science). PMID 42146044 ↗
These are the studies our verdict leans on, chosen from the 1 we read for Guggulsterone. The full linked list is below.
The studies, linked.
1 source behind our Guggulsterone verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialStudy of the Role of the Biliary Salts Nuclear Receptor FXR in Hepatitis C Virus ReplicationClinicalTrials.gov ↗15 participants, Terminated
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 137 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Guggulsterone is, not how risky it is. A report is not proof Guggulsterone caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.